Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value: $100M (100.0% shares, 0.0% debt)

Holdings (27)

SPARK THERAPEUTICS INC 8.3%
Value $8.309M Shares 162,500 Est. Cost $42.99 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 7.8%
Value $7.855M Shares 187,500 Est. Cost $55.90 Unrealized -11.7%
FOUNDATION MEDICINE INC 7.2%
Value $7.277M Shares 390,000 Est. Cost $19.10 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 7.1%
Value $7.134M Shares 430,000 Est. Cost $18.90 Unrealized
LOXO ONCOLOGY INC 6.9%
Value $6.954M Shares 300,000 Est. Cost $27.57 Unrealized
SAGE THERAPEUTICS INC 6.9%
Value $6.885M Shares 228,500 Est. Cost $48.15 Unrealized
BLUEPRINT MEDICINES CORP 6.9%
Value $6.885M Shares 340,000 Est. Cost $26.00 Unrealized
BLUEBIRD BIO INC 5.3%
Value $5.303M Shares 122,500 Est. Cost $60.25 Unrealized
EVH EVOLENT HEALTH INC 4.6%
Value $4.598M Shares 239,500 Est. Cost $13.73 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 4.0%
Value $4.023M Shares 72,500 Est. Cost $83.97 Unrealized -25.0%
KITE PHARMA INC 3.6%
Value $3.625M Shares 72,500 Est. Cost $52.20 Unrealized
GENMARK DIAGNOSTICS INC 3.6%
Value $3.611M Shares 415,000 Est. Cost $8.70 Unrealized
VYGR VOYAGER THERAPEUTICS INC 3.5%
Value $3.544M Shares 322,500 Est. Cost $17.92 Unrealized
EPIZYME INC 3.5%
Value $3.482M Shares 340,000 Est. Cost $14.50 Unrealized
CTMX CYTOMX THERAPEUTICS INC 2.4%
Value $2.392M Shares 234,179 Est. Cost $15.82 Unrealized -27.9%
MYOKARDIA INC 2.2%
Value $2.22M Shares 179,029 Est. Cost $14.07 Unrealized
CLOVIS ONCOLOGY INC 2.0%
Value $2.058M Shares 150,000 Est. Cost $13.72 Unrealized
IGNYTA INC 2.0%
Value $2.033M Shares 375,000 Est. Cost $5.82 Unrealized
SAGE THERAPEUTICS INC 1.9%
Value $1.958M Shares 65,000 Est. Cost $48.15 Unrealized
AVEXIS INC 1.7%
Value $1.711M Shares 45,000 Est. Cost $27.24 Unrealized
TESARO INC 1.7%
Value $1.681M Shares 20,000 Est. Cost $84.05 Unrealized
XBI SPDR SERIES TRUST 1.6%
Value $1.622M Shares 30,000 Est. Cost Unrealized
BMY BRISTOL MYERS SQUIBB CO 1.5%
Value $1.545M Shares 21,000 Est. Cost $46.69 Unrealized +8.1%
DXCM DEXCOM INC 1.2%
Value $1.19M Shares 15,000 Est. Cost $18.45 Unrealized -7.7%
DXCM DEXCOM INC 1.2%
Value $1.19M Shares 15,000 Est. Cost $18.45 Unrealized -7.7%
SYROS PHARMACEUTICALS INC 0.9%
Value $908K Shares 50,000 Est. Cost $18.16 Unrealized
MEDGENICS INC 0.5%
Value $472K Shares 85,000 Est. Cost $5.55 Unrealized